Partnership for Glaucoma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00672048 |
Recruitment Status
:
Completed
First Posted
: May 6, 2008
Last Update Posted
: January 6, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Glaucoma | Other: Computer Tablet Other: Continuing Education Course Other: Continuing education | Not Applicable |
Glaucoma is a leading cause of blindness and visual impairment in the United States, particularly among disadvantaged populations. Despite the presence of therapies proven in NEI, randomized controlled trials that can be delivered by more than 18,000 ophthalmologists and 34,000 optometrists, almost nothing is known about the content and quality of glaucoma care delivered by non-MD providers such as optometrists. With the numbers of people with glaucoma expected to more than double in the next twenty years in the face of no more than a 15% increase in the supply of eye care providers, methods to better support appropriate and high-quality care for chronic eye diseases such as glaucoma delivered by optometrists will become as critical, if not more so, as techniques to enhance quality care among ophthalmologists.
Our study is a community-based, randomized, controlled trial that evaluates the suitability and effectiveness of a technology-based (tablet computer) intervention within the context of a novel partnership between optometrists and patients with glaucoma to improve the process quality of care and ultimately outcomes of care. By using successfully implemented technology in novel applications,and by building on the success of ongoing community-based quality improvement projects in our region, the study provides a means for rapid translation into community care if the intervention is successful.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 721 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Expanding Quality Care for Glaucoma Through a Provider-Patient Partnership |
Study Start Date : | October 2007 |
Actual Primary Completion Date : | July 2013 |
Actual Study Completion Date : | July 2013 |

Arm | Intervention/treatment |
---|---|
1 |
Other: Computer Tablet
A tablet computer based software application designed to collect structured clinical information from providers and patients at the point of care.
Other: Continuing Education Course
Annual standard continuing education
|
2
Control group to receive annual continuing education
|
Other: Continuing education
Annual standard continuing education materials
|
- To determine if innovative technology will improve process quality of care & important outcomes of care by optometrists in a cost-efficient manner while simultaneously empowering & including patients as part of the care process. [ Time Frame: Baseline, Year 1 and Year 2 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-Diagnosis of open angle glaucoma with documented visual field loss.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00672048
United States, Alabama | |
University of Alabama | |
Birmingham, Alabama, United States, 35204 | |
United States, North Carolina | |
Duke University | |
Durham, North Carolina, United States, 27705 |
Principal Investigator: | Paul Lee, MD, JD | Duke University |
Publications:
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT00672048 History of Changes |
Obsolete Identifiers: | NCT01733498 |
Other Study ID Numbers: |
Pro00002593 R01EY018405-01 ( U.S. NIH Grant/Contract ) |
First Posted: | May 6, 2008 Key Record Dates |
Last Update Posted: | January 6, 2014 |
Last Verified: | December 2013 |
Keywords provided by Duke University:
glaucoma optometrists |
Additional relevant MeSH terms:
Glaucoma Ocular Hypertension Eye Diseases |